Table 3.
Danoprevir | LPV/r | P value | |
---|---|---|---|
Cases | 5 | 28 | |
Negative NAT, d | |||
Median | 7.0 | 12.0 | .7903 |
Average | 8.0 | 12.5 | .0388* |
Hospital stays, d | |||
Median | 9.0 | 17.0 | .6802 |
Average | 11.4 | 16.7 | .0324* |
Abbreviations: COVID‐19, coronavirus disease 2019; LPV/r, lopinavir/ritonavir; NAT, nucleic acid testing.
P < .05 was considered statistically significant.